InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,420.25
(
-0.01%
)
US TECH 100
19,074.00
(
0.57%
)
Dow Jones
38,478.57
(
-0.60%
)
Brent Oil
82.10
(
-0.25%
)
Bitcoin
66,470.14
(
-2.61%
)

Replies to post #244100 on Biotech Values

Replies to #244100 on Biotech Values

DewDiligence

03/27/24 4:29 AM

#251229 RE: DewDiligence #244100

FDA approves MRK’s Winrevair—(sotatercept)—for PAH:

https://www.businesswire.com/news/home/20240326077272/en

This is the first approved drug for PAH that is thought to be disease modifying. MRK acquired sotatercept in the $11.5B buyout of XRLN in 2021 (#msg-166156870).